Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
USE CASES
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
PatSnap Eureka Desktop
NEWAnalytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
NEWServices professionnels
Cabinets d'avocats
Sciences de la vie
Haute technologie
Competitor Tech Research
Design Risk Screening
Cosmetic Formulation
Telecom SEP Claim Chart
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport Tetravalent vaccines, NS5 inhibitors, and monoclonal antibodies reshaping the dengue drug pipeline. Analysis of TAK-003, JNJ-1802, VIS513, and beyond.
Article | Rapport Nanofluid heat transfer technology landscape 2026: ternary hybrids, 2D nanomaterials, AI-augmented design, and the commercialisation gap across solar, data centre, and electronics cooling.
Article | Rapport How do deterministic and probabilistic thresholds differ in automated X-ray inspection of solder joints? A deep-dive into AXI decision logic, POD curves, and false-call trade-offs.
Article | Rapport Explore the emerging drug pipeline for CHARGE syndrome and CHD7-related disorders: epigenetic correction, MAPK/ERK targets, LSD1 inhibitors, and neurodevelopmental approaches.
Article | Rapport Why scaling electrochemical polishing to complex internal channels in additively manufactured heat exchangers is one of manufacturing's hardest unsolved problems.
Article | Rapport Comprehensive FOG technology landscape 2026: patent evidence, hollow-core fiber RFOGs, ASIC integration, and strategic IP signals from 1984–2025.
Article | Rapport How friction stir welding joins dissimilar aluminum-copper busbars in EV battery packs—covering IMC suppression, process variants, patent landscape, and competing technologies.
Article | Rapport TPV efficiency has surpassed 40% in lab demonstrations. Explore the 2026 thermophotovoltaic technology landscape: emitter engineering, near-field TPV, and grid-scale applications.
Article | Rapport MEK inhibitors, trametinib, and RASopathy drug pipeline: how PTPN11, RAF1, and KRAS mutations drive Noonan syndrome and what the emerging therapies target.
Article | Rapport How friction stir welding joins dissimilar aluminum-copper busbars in EV battery packs—suppressing IMCs, enabling cross-section engineering, and what the patent landscape reveals.
Article | Rapport TPV efficiency has surged from ~1% to 40%+ in 12 years. Explore the 2026 thermophotovoltaic technology landscape: emitter design, near-field TPV, and grid-scale applications.
Article | Rapport MEK inhibitors like trametinib are reshaping Noonan syndrome treatment. Explore the RASopathy drug pipeline, PTPN11 targets, and growth pathway correction approaches.
Article | Rapport Map the 2026 soft lithography fabrication landscape: PDMS stamps, UV nanoimprint, biomedical devices, display manufacturing, and emerging self-healing stamp materials.
Article | Rapport LP-DED vs binder jetting for large-format metal part repair: process differences, microstructure, key patents, and why LP-DED dominates direct in-situ repair.
Article | Rapport CDG drug pipeline: enzyme replacement, substrate supplementation, gene therapy, and pharmacological chaperones across 130+ glycosylation subtypes. Analysis from PatSnap.